Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Cancer & Metabolism
|
December 8, 2017
PKM2 is not required for colon cancer initiated by APC loss
Allison N Lau, William J Israelsen, Jatin Roper, et al.
Plos One
|
October 4, 2011
The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer
Jatin Roper, Michael P Richardson, Wei Vivian Wang, et al.
Cell Stem Cell
|
July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
Priscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 2, 2022
Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
Laura W Bowers, Elaine M Glenny, Arunima Punjala, et al.
Disease Models & Mechanisms
|
April 19, 2014
Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease
Peter J Belmont, Eva Budinska, Ping Jiang, et al.
The Journal of Biological Chemistry
|
May 4, 2007
Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation
Michael H Pillinger, Nada Marjanovic, Seok-Yong Kim, et al.
Cancer Letters
|
March 1, 2014
Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer
Jatin Roper, Mark J Sinnamon, Erin M Coffee, et al.
Nature Communications
|
July 19, 2023
Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin
Alfredo Erazo-Oliveras, Mónica Muñoz-Vega, Mohamed Mlih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2013
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer
Erin M Coffee, Anthony C Faber, Jatin Roper, et al.
The EMBO Journal
|
September 11, 2020
Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells
Huajun Han, Laurie A Davidson, Yang-Yi Fan, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Cancer & Metabolism
|
December 8, 2017
PKM2 is not required for colon cancer initiated by APC loss
Allison N Lau, William J Israelsen, Jatin Roper, et al.
Plos One
|
October 4, 2011
The dual PI3K/mTOR inhibitor NVP-BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild-type colorectal cancer
Jatin Roper, Michael P Richardson, Wei Vivian Wang, et al.
Cell Stem Cell
|
July 31, 2020
Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
Priscilla Cheung, Jordi Xiol, Michael T Dill, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 2, 2022
Weight Loss and/or Sulindac Mitigate Obesity-associated Transcriptome, Microbiome, and Protumor Effects in a Murine Model of Colon Cancer
Laura W Bowers, Elaine M Glenny, Arunima Punjala, et al.
Disease Models & Mechanisms
|
April 19, 2014
Cross-species analysis of genetically engineered mouse models of MAPK-driven colorectal cancer identifies hallmarks of the human disease
Peter J Belmont, Eva Budinska, Ping Jiang, et al.
The Journal of Biological Chemistry
|
May 4, 2007
Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation
Michael H Pillinger, Nada Marjanovic, Seok-Yong Kim, et al.
Cancer Letters
|
March 1, 2014
Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancer
Jatin Roper, Mark J Sinnamon, Erin M Coffee, et al.
Nature Communications
|
July 19, 2023
Mutant APC reshapes Wnt signaling plasma membrane nanodomains by altering cholesterol levels via oncogenic β-catenin
Alfredo Erazo-Oliveras, Mónica Muñoz-Vega, Mohamed Mlih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2013
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer
Erin M Coffee, Anthony C Faber, Jatin Roper, et al.
The EMBO Journal
|
September 11, 2020
Loss of aryl hydrocarbon receptor potentiates FoxM1 signaling to enhance self-renewal of colonic stem and progenitor cells
Huajun Han, Laurie A Davidson, Yang-Yi Fan, et al.
Page
of 8